From other sites
Nymox Announces Prostate Cancer Clinical Trial Will Complete Prospective 18 Month Post-Treatment Assessmentsat 4-traders.com (Thu, 11:01AM)
at 4-traders.com (May 15, 2015)
at Benzinga.com (Dec 18, 2014)
at MarketWatch.com (Dec 17, 2010)
NYMX vs. ETF Alternatives
Nymox Pharmaceutical Corp along with its subsidiaries is a biopharmaceutical corporation, engaged in research & development of diagnostics & drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Other News & PR